Exuberas Effects

Exubera

The Effects on Diabetics

Exubera and its effects on diabetes

The release of Exubera, the world’s first inhaled insulin therapy to be approved by the Food and Drug Administration, will have significant effects on diabetics nationwide. Produced by Pfizer, this technological advance in medication provides a solution for many people who, in the past, have refused any type of insulin.

Exubera will have an effect on diabetics for the better, allowing those who have an aversion to needles to avoid daily injections and still receive the needed medication to keep glucose levels normal. This form of insulin therapy will also have an effect on diabetics who depend on insulin therapy now. Although injections of long term insulin will still be required, Exubera will allow many daily shots to be replaced by simply inhaling a small packet of powder through a device that is about the size of a case for glasses.

The effects on diabetics of the release of Exubera will also include the ability to medicate in public without feeling like a social piranha. For years, insulin dependent diabetics have been expected to “disappear” while administering an injection. With an inhaled form of insulin, treating themselves in public will be as acceptable as taking a pain killer or using an asthma inhaler.

Exubera’s effects on diabetics will be life altering. No longer will it be necessary to plan meal times as carefully, since Exubera is a very fast-acting insulin that can be taken just minutes before a meal. This means that diabetics can go about their business in a normal fashion, rather than interrupting their day or planning around their disease.

The freedom offered by Exubera is incredible, and this will be one of the most noticed effects on diabetics. The device used to inhale the powdered form of insulin is about the size of a glasses case and easily transported. With no syringes required, traveling will be much less hassle. Overall, the effect on diabetics will make life much more livable for the average insulin user.

This is an absolutely independent news site reporting on Exubera, an insulin delivery system developed by Pfizer or Aventis, which plans to market it under the trademarked name Exubera. Nothing on this website is intended to infringe on that trademark in any way nor is anything on this website is intended to be medical advice. All information provided here is just to be used for informational purposes. Note that you should always consult a doctor with any questions you may have regarding a medical condition.